The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $216.56

Today's change+1.78 +0.83%
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $216.56

Today's change+1.78 +0.83%
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.

Allergan plc up (U.S.)$1.78

Allergan plc closed up Wednesday by (U.S.)$1.78 or 0.83% to (U.S.)$216.56. Over the last five days, shares are unchanged, but down 26.65% for the last 52 weeks. This security has underperformed the S&P 500 by 47.47% during the last year.

Key company metrics

  • Open(U.S.) $216.50
  • Previous close(U.S.) $214.78
  • High(U.S.) $219.13
  • Low(U.S.) $214.70
  • Bid / Ask(U.S.) $215.60 / (U.S.) $217.28
  • YTD % change+3.12%
  • Volume2,680,001
  • Average volume (10-day)4,412,210
  • Average volume (1-month)4,528,825
  • Average volume (3-month)4,719,085
  • 52-week range(U.S.) $184.50 to (U.S.) $301.98
  • Beta1.07
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.05×
  • Forward PEG1.42×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.29%
  • Trailing EPS(U.S.) -$4.94
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue3,6223,6853,3994,198
Total other revenue--------
Total revenue3,6223,6853,3994,198
Gross profit3,1603,2432,9223,087
Total cost of revenue4624424771,111
Total operating expense3,8894,1723,5714,738
Selling / general / administrative1,1571,2101,0961,327
Research & development665905409445
Depreciation / amortization1,6091,6331,5901,587
Interest expense (income), net operating--------
Unusual expense (income)-5-18-2269
Other operating expenses, total--------
Operating income-266-488-172-540
Interest income (expense), net non-operating-324-346-333-341
Gain (loss) on sale of assets--------
Other--------
Income before tax-539-681-501-874
Income after tax-380-423-92-769
Income tax, total-159-258-409-105
Net income15,220-502256-631
Total adjustments to net income-70-70-70-70
Net income before extra. items-382-424-93-771
Minority interest-2-2-1-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-452-494-163-840
Inc. avail. to common incl. extra. items15,150-571186-701
Diluted net income15,150-571186-701
Dilution adjustment--------
Diluted weighted average shares393396395395
Diluted EPS excluding extraordinary itemsvalue per share-1.15-1.25-0.41-2.13
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-1.16-1.28-0.41-1.69